Advanced search
Publication Cover
Cancer Investigation Volume 28, 2010 - Issue 1
Submit an article Journal homepage
25
Views
2
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

Bevacizumab may be Active in Myelofibrosis

Ilias NikolaidisOncology Unit, 3rd Department of Medicine, Sotiria General Hospital, Athens School of Medicine, Greece, 1st Department of Medicine, Laiko General Hospital, Athens School of Medicine, Greece.
,
Nektaria MakriliaOncology Unit, 3rd Department of Medicine, Sotiria General Hospital, Athens School of Medicine, Greece, 1st Department of Medicine, Laiko General Hospital, Athens School of Medicine, Greece.
,
Vassilia XylaOncology Unit, 3rd Department of Medicine, Sotiria General Hospital, Athens School of Medicine, Greece, 1st Department of Medicine, Laiko General Hospital, Athens School of Medicine, Greece.
,
Kalliopi DilanaOncology Unit, 3rd Department of Medicine, Sotiria General Hospital, Athens School of Medicine, Greece, 1st Department of Medicine, Laiko General Hospital, Athens School of Medicine, Greece.
,
Dimitris StathopoulosOncology Unit, 3rd Department of Medicine, Sotiria General Hospital, Athens School of Medicine, Greece, 1st Department of Medicine, Laiko General Hospital, Athens School of Medicine, Greece.
,
Ioannis MeletisOncology Unit, 3rd Department of Medicine, Sotiria General Hospital, Athens School of Medicine, Greece, 1st Department of Medicine, Laiko General Hospital, Athens School of Medicine, Greece.
&
Kostas SyrigosOncology Unit, 3rd Department of Medicine, Sotiria General Hospital, Athens School of Medicine, Greece, 1st Department of Medicine, Laiko General Hospital, Athens School of Medicine, Greece.Correspondence[email protected] [email protected]
 show all
Pages 111-112 | Published online: 09 Dec 2009
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

ABSTRACT

A case of a 69-year-old woman with myelofibrosis presenting with non-small cell lung cancer was reported at Sotiria General Hospital in Athens. She was administered bevacizumab infusions biweekly and a great decrease in the number of her white blood cells was observed. Such low levels of white blood cells had never been reached in the past, when she was receiving hydroxyurea.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,193.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.